These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11815715)

  • 1. Angiogenesis in chronic myeloproliferative diseases.
    Di Raimondo F; Palumbo GA; Molica S; Giustolisi R
    Acta Haematol; 2001; 106(4):177-83. PubMed ID: 11815715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
    Panteli K; Zagorianakou N; Bai M; Katsaraki A; Agnantis NJ; Bourantas K
    Eur J Haematol; 2004 Jun; 72(6):410-5. PubMed ID: 15128419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow angiogenesis: methods of quantification and changes evolving in chronic myeloproliferative disorders.
    Kvasnicka HM; Thiele J
    Histol Histopathol; 2004 Oct; 19(4):1245-60. PubMed ID: 15375769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels, and bone marrow immunohistochemical expression of, vascular endothelial growth factor in patients with chronic myeloproliferative diseases.
    Panteli K; Bai M; Hatzimichael E; Zagorianakou N; Agnantis NJ; Bourantas K
    Hematology; 2007 Dec; 12(6):481-6. PubMed ID: 17852434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis.
    Di Raimondo F; Azzaro MP; Palumbo GA; Bagnato S; Stagno F; Giustolisi GM; Cacciola E; Sortino G; Guglielmo P; Giustolisi R
    Leukemia; 2001 Jun; 15(6):976-80. PubMed ID: 11417486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of myelofibrosis in chronic myeloproliferative disorders].
    Nagao T; Yonekura S
    Rinsho Ketsueki; 1988 Jul; 29(7):983-8. PubMed ID: 2846914
    [No Abstract]   [Full Text] [Related]  

  • 8. Megakaryocytes and platelets in myeloproliferative disorders.
    Briere J; Kiladjian JJ; Peynaud-Debayle E
    Baillieres Clin Haematol; 1997 Feb; 10(1):65-88. PubMed ID: 9154316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia.
    Arora B; Ho CL; Hoyer JD; Mesa RA; Tefferi A
    Haematologica; 2004 Dec; 89(12):1454-8. PubMed ID: 15590395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of vascular endothelial growth factor receptor 1 correlates with VEGF and microvessel density in Philadelphia chromosome-negative myeloproliferative neoplasms.
    Boiocchi L; Vener C; Savi F; Bonoldi E; Moro A; Fracchiolla NS; Iurlo A; Deliliers GL; Coggi G; Bosari S; Gianelli U
    J Clin Pathol; 2011 Mar; 64(3):226-31. PubMed ID: 21217153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases.
    Panteli KE; Hatzimichael EC; Bouranta PK; Katsaraki A; Seferiadis K; Stebbing J; Bourantas KL
    Br J Haematol; 2005 Sep; 130(5):709-15. PubMed ID: 16115126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations.
    Lekovic D; Gotic M; Skoda R; Beleslin-Cokic B; Milic N; Mitrovic-Ajtic O; Nienhold R; Sefer D; Suboticki T; Buac M; Markovic D; Diklic M; Cokic VP
    Ann Hematol; 2017 Mar; 96(3):393-404. PubMed ID: 27924369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations.
    Boveri E; Passamonti F; Rumi E; Pietra D; Elena C; Arcaini L; Pascutto C; Castello A; Cazzola M; Magrini U; Lazzarino M
    Br J Haematol; 2008 Jan; 140(2):162-8. PubMed ID: 18028479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Dkk3 protein expression in platelets and megakaryocytes of patients with myeloproliferative neoplasms.
    Medinger M; Tzankov A; Kern J; Pircher A; Hermann M; Ott HW; Gastl G; Untergasser G; Gunsilius E
    Thromb Haemost; 2011 Jan; 105(1):72-80. PubMed ID: 20978717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia.
    Mesa RA; Hanson CA; Rajkumar SV; Schroeder G; Tefferi A
    Blood; 2000 Nov; 96(10):3374-80. PubMed ID: 11071630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia.
    Zhelyazkova AG; Tonchev AB; Kolova P; Ivanova L; Gercheva L
    Scand J Clin Lab Invest; 2008; 68(6):492-500. PubMed ID: 18609087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification.
    Buhr T; Georgii A; Choritz H
    Pathol Res Pract; 1993 Mar; 189(2):121-32. PubMed ID: 8321741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of oncostatin M as a JAK2 V617F-dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms.
    Hoermann G; Cerny-Reiterer S; Herrmann H; Blatt K; Bilban M; Gisslinger H; Gisslinger B; Müllauer L; Kralovics R; Mannhalter C; Valent P; Mayerhofer M
    FASEB J; 2012 Feb; 26(2):894-906. PubMed ID: 22051730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.